Selank and BDNF: Brain-Derived Neurotrophic Factor

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Selank is a synthetic peptide that boosts brain-derived neurotrophic factor (BDNF) levels, supporting cognition, mood, and stress resilience. Patients typically see improved focus and reduced anxiety within 7-14 days when dosing 250mcg twice daily intranasally.

Selank's Effect on BDNF: What Clinicians Should Know

Selank is a heptapeptide originally developed in Russia for anxiety and cognitive disorders. Clinically, it's recognized for its ability to raise brain-derived neurotrophic factor (BDNF), a protein critical for synaptic plasticity, memory formation, and neuronal survival.

Why BDNF Matters in Neuropsychiatry

BDNF acts as a growth factor in the brain, promoting neuron survival and enhancing synaptic strength. Low BDNF levels correlate with depression, anxiety, and cognitive decline (Kowia
4a, 2017). Therapeutics that increase BDNF are prime candidates for treating these conditions.

How Selank Interacts With BDNF

Studies in rodent models demonstrate Selank significantly elevates BDNF mRNA expression in the hippocampus, a key center for learning and memory (Kozlovsky et al., 2013). This upregulation improves synaptic plasticity, which translates clinically to better cognitive processing and mood stabilization.

Unlike traditional anxiolytics such as benzodiazepines, which primarily affect GABA receptors and induce sedation, Selank modulates the balance of neurotransmitters including serotonin and dopamine, while indirectly enhancing BDNF levels. This dual action explains its anxiolytic effects without common side effects like sedation or dependence.

Dosage and Clinical Response

Typical dosing protocols involve 250mcg administered intranasally twice daily. In clinical settings, patients often notice reduced anxiety and improved focus within 7 to 14 days. However, individual response varies due to differences in baseline BDNF expression and receptor sensitivity.

Higher doses—above 500mcg twice daily—have not shown proportionally greater benefits and may increase risk of mild irritability. Therefore, sticking to established dosing is advisable.

Comparing Selank to Other BDNF Modulators

Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine also increase BDNF but usually require 4 to 6 weeks for measurable changes. Selank's faster onset and fewer side effects make it a compelling alternative for patients needing quicker relief from anxiety and cognitive issues.

However, unlike physical exercise, which robustly increases systemic and central BDNF, Selank specifically targets central nervous system pathways without affecting peripheral BDNF levels. This targeted mechanism can be beneficial for patients unable to engage in regular physical activity.

Potential Mechanisms Behind Selank's BDNF Increase

• Modulation of cytokine levels: Selank reduces pro-inflammatory cytokines that typically suppress BDNF transcription (Petrova et al., 2016).
• Enhancement of neurotrophic support: By acting on the opioid system, Selank indirectly stimulates neuronal survival pathways linked to BDNF expression.
• Regulation of monoamine neurotransmitters: It adjusts serotonin and dopamine levels, which themselves influence BDNF synthesis.

Clinical Nuances

Selank shows promise for patients with generalized anxiety disorder, mild cognitive impairment, and post-stroke neurorehabilitation due to its BDNF-mediated effects. Still, it might not be effective for severe depressive disorders where multiple neurotransmitter systems are disrupted.

Additionally, some patients report minimal cognitive improvement despite reduced anxiety. This could stem from individual variations in BDNF receptor density or concurrent neurodegenerative changes that limit peptide efficacy.

Practical Takeaway for Prescribers

For patients struggling with anxiety and cognitive fog, starting Selank at 250mcg intranasally twice daily offers a rapid route to boosting BDNF and enhancing neuroplasticity. Monitor response over 2 weeks and adjust if needed. Avoid combining Selank with benzodiazepines as their mechanisms differ and co-administration is not well studied.

Regular cognitive assessments and anxiety scales help track progress. If improvements plateau, consider adjunctive strategies like aerobic exercise or SSRIs to further raise BDNF.

Overall, Selank provides a unique, targeted approach to elevate BDNF and support brain health without the drawbacks of traditional anxiolytics.